Adagloxad simolenin plus OBI-821 shows no survival benefit compared to standard of care in triple-negative breast cancer

Omission of axillary lymph node dissection reduces arm morbidity without compromising survival in select breast cancer cases

ASCO 2026: Breast cancer overview

ctDNA positivity predicts poor response and recurrence risk in triple-negative breast cancer

Education and training in breast cancer care

Can public–private partnerships accelerate cancer research and clinical trials in LMICs?

Understanding breast cancer care systems with the BCCi

Strengthening cancer prevention through the Latin American cancer code

Creating a visual resource for breast cancer reconstruction

From lived experience to informed choice in breast cancer reconstruction

Exploring genetic essentiality and drug sensitivity in triple-negative breast cancer

Improving African representation in breast cancer genomics